Iyer 2012 Hum Gene Ther

From Bioblast
Jump to: navigation, search
Publications in the MiPMap
Iyer S, Bergquist K, Young K, Gnaiger E, Rao RR, Bennett JP Jr (2012) Mitochondrial gene therapy improves respiration, biogenesis and transcription in G11778A Leber’s hereditary optic neuropathy and T8993G Leigh’s syndrome cells. Hum Gene Ther 23:647-57.

» PMID: 22390282 Open Access

Iyer S, Bergquist K, Young K, Gnaiger E, Rao RR, Bennett JP (2012) Hum Gene Ther

Abstract: Many incurable mitochondrial disorders result from mutant mitochondrial DNA (mtDNA) and impaired respiration. Leigh’s syndrome (LS) is a fatal neurodegenerative disorder of infants and Leber’s hereditary optic neuropathy (LHON) causes blindness in young adults. Treatment of LHON and LS cells respectively harboring G11778A and T8993G mutant mtDNA by >90%, with healthy donor mtDNA complexed with recombinant human mitochondrial transcription factor A (rhTFAM), improved mitochondrial respiration by ~1.2 fold in LHON cells and restored ~>50% ATP synthase function in LS cells. Mitochondrial replication, transcription and translation of key respiratory genes and proteins were increased in the short term. Increased NRF1, TFAMB1 and TFAMA expression alluded to the activation of mitochondrial biogenesis as a mechanism for improving mitochondrial respiration. These results represent the development of a therapeutic approach for LHON and LS patients in the near future.

Keywords: TFAM, mtDNA, Leigh’s syndrome, LHON disease, Mitochondrial respiration, Biogenesis, Transcription, Diseased fibroblast, Cybrid cells

O2k-Network Lab: US VA Richmond Iyer S, US VA Richmond Bennett JP, AT Innsbruck Gnaiger E, AT Innsbruck MitoCom


Labels: MiParea: Respiration, mt-Biogenesis;mt-density, Genetic knockout;overexpression, mt-Medicine  Pathology: Inherited 

Organism: Human  Tissue;cell: Fibroblast  Preparation: Intact cells 


Coupling state: OXPHOS 

HRR: Oxygraph-2k